An AllTrials project

NCT05118750: An ongoing trial by Alto Neuroscience

This trial is completed, but has been granted a delay in reporting its results. It must report results 1 week, 3 days from now.

Full data

Full entry on ClinicalTrials.gov NCT05118750
Title An Open-label Study of ALTO-300 in Adults With Major Depressive Disorder
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Dec. 13, 2021
Completion date May 5, 2023
Required reporting date May 5, 2026, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov April 23, 2026
Days late None